Results 151 to 160 of about 9,466,795 (394)
Riesgo operacional: reto actual de las entidades financieras
El presente artículo es uno de los resultados de un proyecto de investigación sobre gestión integral del riesgo operacional, promovido por la Vicerrectoría de Investigaciones de la Universidad de Medellín.
Juan Camilo Arbeláez +12 more
doaj
Data Analytics for Operational Risk Management
O. Araz +3 more
semanticscholar +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
Bayesian Methods for Measuring Operational Risk [PDF]
The likely imposition by regulators of minimum standards for capital to cover 'other risks' has been a driving force behind the recent interest in operational risk management.
Carol Alexander
core
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath +13 more
wiley +1 more source
Understanding the Internal Measurement Approach to Assessing Operational Risk Capital [PDF]
The recent publication by the Basel Committee of CP2.5, the working paper on Operational Risk Capital Charges, has shed new light on the methods that will be proposed for the measurement of operational risks in the Basel II Accord.
Carol Alexander
core
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source

